CAS 212631-67-9
:PD184161
Description:
PD184161, with the CAS number 212631-67-9, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its role as a selective inhibitor of certain protein kinases. This compound is characterized by its ability to modulate specific signaling pathways, making it a subject of interest in cancer research and other therapeutic areas. PD184161 is known for its relatively high potency and selectivity, which can lead to reduced off-target effects compared to less selective inhibitors. Its chemical structure typically includes functional groups that contribute to its binding affinity and biological activity. Additionally, PD184161 has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are crucial for evaluating its potential as a therapeutic agent. Overall, PD184161 represents a valuable tool in the exploration of targeted therapies, particularly in the context of diseases driven by aberrant kinase activity.
Formula:C17H13BrClF2IN2O2
InChI:InChI=1S/C17H13BrClF2IN2O2/c18-11-6-10(17(25)24-26-7-8-1-2-8)16(15(21)14(11)20)23-13-4-3-9(22)5-12(13)19/h3-6,8,23H,1-2,7H2,(H,24,25)
InChI key:InChIKey=VJNZMSLGVUSPCF-UHFFFAOYSA-N
SMILES:N(C1=C(C(NOCC2CC2)=O)C=C(Br)C(F)=C1F)C3=C(Cl)C=C(I)C=C3
Synonyms:- 5-Bromo-2-[(2-chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluorobenzamide
- PD 184161
- Benzamide, 5-bromo-2-[(2-chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluoro-
- 5-Bromo-2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide
- PF-1529483
- MEK1/2 Inhibitor IV - CAS 212631-67-9 - Calbiochem
- PF-3011370
- UK-287074
- MEK1/2 Inhibitor IV
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
5-Bromo-2-((2-Chloro-4-Iodophenyl)Amino)-N-(Cyclopropylmethoxy)-3,4-Difluorobenzamide
CAS:5-Bromo-2-((2-Chloro-4-Iodophenyl)Amino)-N-(Cyclopropylmethoxy)-3,4-DifluorobenzamidePurity:99%Molecular weight:557.56g/molPD184161
CAS:<p>PD184161 is a novel, orally-active MEK inhibitor. PD184161 inhibited MEK activity (IC50 = 10-100 nM) in a time- and concentration-dependent manner[1].</p>Formula:C17H13BrClF2IN2O2Purity:99.40%Color and Shape:SolidMolecular weight:557.56PD-184161
CAS:Controlled Product<p>Applications PD-184161 is a novel mitogen-activated protein kinase kinase (MEK) inhibitor shown to exhibit antitumor effects and suppress MEK-extracellular signal-related kinase signaling activity and cell proliferation in human hepatocellular carcinoma cells and in human hepatocellular carcinoma xenografts.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Yip-Schneider, M.T. et al.: J. Pharmacol. Exp. Therap., 329, 1063 (2009); Klein, P.J. et al.: Neoplasia, 8, 1 (2006); Yung, H.W. et al.: Biochem. Pharmacol., 68, 351 (2004);<br></p>Formula:C17H13BrClF2IN2O2Color and Shape:NeatMolecular weight:557.5556PD 184161
CAS:<p>Inhibitor of MEK kinases</p>Formula:C17H13BrClF2IN2O2Purity:Min. 95%Molecular weight:557.56 g/mol






